Altas dosis de doxorrubicina de intensidad en el linfoma no Hodgkin agresivo: una literatura basada en meta-análisis

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2011
Cargando información sobre las referencias

CRD SUMMARY:

This review concluded that high-dose intensity doxorubicin based combination chemotherapy regimens should be considered for the treatment of aggressive non-Hodgkin's lymphoma. Given the unclear quality and variability between the included trials, this conclusion may not be reliable.
Epistemonikos ID: 03832b94acfe24b83d01b5e8eb5aaf8f0f66f6b5
First added on: Jun 07, 2012